Filing Details
- Accession Number:
- 0001246360-12-003162
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-23 18:10:10
- Reporting Period:
- 2012-07-19
- Filing Date:
- 2012-07-23
- Accepted Time:
- 2012-07-23 17:10:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 911326 | Synageva Biopharma Corp | GEVA | Biological Products, (No Disgnostic Substances) (2836) | 561808663 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532219 | Anthony Quinn | 128 Spring Street, Suite 520 Lexington MA 02421 | Svp, Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-07-19 | 1,900 | $0.95 | 21,935 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-07-19 | 1,900 | $50.00 | 20,035 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-07-20 | 600 | $0.95 | 20,635 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-07-20 | 600 | $50.00 | 20,035 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-07-19 | 1,900 | $0.00 | 1,900 | $0.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-07-20 | 600 | $0.00 | 600 | $0.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 57,064 | 2019-10-07 | No | 4 | M | Direct | |
| 56,464 | 2019-10-07 | No | 4 | M | Direct |
Footnotes
- The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 24, 2012.
- The Stock Option granted the reporting person an option to purchase 101,080 shares of Common Stock (the "Shares"). 25% of the Shares vested and became exercisable on 08/31/2010, and 1/36 of the remainder of the Shares vest and become exercisable monthly thereafter.
Billionaire Hedge Funds
